Distell enters the medical cannabis market

Organisation: Position: Deadline Date: Location:

South African liquor group Distell and Invenfin, the venture capital arm of Remgro, have entered into a partnership with Releaf Pharmaceuticals to share ownership in South African cannabis wellness brand Rethink. Bizcommunity reports that Distell and Invenfin have each purchased a 20% stake in the Rethink brand and range of products to establish a three-way partnership, with a vision of building a compelling portfolio of cannabis-based brands across product categories in this growing sector.

Rethink was launched by Releaf Pharmaceuticals in October 2019. The product range includes CBD oils, capsules, teas and skincare products, which are available in leading national and independent pharmacies.

With its strong technical and regulatory expertise in the cannabis industry and a broad market footprint, Releaf Pharmaceuticals is responsible for the successful growth of Rethink, which is the first cannabis wellness brand to be endorsed by the Cannabis Research Institute. With a worldwide shift towards legalisation of cannabis products, the sector is poised for growth with an estimated global market size of $166bn. In South Africa, CBD preparations containing no more than 20mg per daily dose have been allowed to be sold legally since 2019.

 

Full Bizcommunity report

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.